All News

Researchers looked at data from the Surveillance, Epidemiology, and End Results database to see if there has been any increase in the use of active surveillance or watchful waiting when it comes to low-risk prostate cancer.

How much do you know about the epidemiology and prognosis of ovarian cancer? Here's your chance to find out.

A 41-year-old woman presents with a palpable mass in her left breast. A lumpectomy is performed. What is your diagnosis?

In 2017, about half of physician directors at National Cancer Institute cancer centers received payments related to research, while a quarter received payments over $5,000 that were not related to research.

The United States Preventive Services Task Force issued a statement reaffirming its 2004 recommendation against screening for pancreatic cancer in asymptomatic adults.

A phase III trial found bevacizumab and pemetrexed were effective as a maintenance therapy, but researchers do not recommend it to treat non–small-cell lung cancer.

Researchers tried using deep machine learning to anticipate disease outcomes and progression in patients with lung cancer.

The phase II study compared single-agent anti-EGFR panitumumab to panitumumab combined with fluorouracil-leucovorin in patients with RAS wild-type metastatic colorectal cancer.

Researchers examined the rate and risk of late-onset anorectal disease among childhood cancer survivors.

Researchers looked at diagnosis, assessment, treatment, and prognosis of women diagnosed with cervical cancer while pregnant.

This new study looked at chronic pain rates among cancer survivors, including which survivors report the highest prevalence of pain.

A survey of oncologists found child care is a significant concern of women in the field and can greatly impact their conference attendance compared to their male counterparts.

A new study offers hope in predicting glioblastoma responses to chemotherapy, radiation, and combination therapy.

The risk of multiple primary cancers is increasing due to increasing numbers of survivors, long-term side effects of chemotherapy and/or radiation therapy, increased diagnostic sensitivity, and persisting effects of genetic and behavioral risk factors.

Researchers looked at whether or not a two-dose recombinant zoster vaccine would reduce the incidence of herpes zoster in patients with hematologic malignancies after autologous stem cell transplantation.

A new study estimated that cancer deaths in 2015 resulted in billions in lost earnings in the United States.

This study adds to the evidence that the decline in access to local care due to the shuttering of rural hospitals and community cancer clinics adversely affects cancer patients.

The FDA approved selinexor in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma.

Healthy eating, exercise, and avoiding smoking can save lives. So why aren't more doctors talking to patients about lifestyle changes?

The FDA approved daratumumab in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.

A new trial investigated the efficacy of XELOX vs GEMOX as first-line therapy for advanced biliary tract cancers.

Many patients complain of "chemo brain," or a drop in cognitive function during or after receiving chemotherapy, but there are strategies to manage chemo brain, as well as research on how chemotherapy affects the brain long-term.

This article reviews the prevalence of suicide in patients with cancer, risk factors, related conditions, and interventions to identify and treat suicidal patients.

The FDA approved pembrolizumab as a treatment option for patients with metastatic small-cell lung cancer.

The FDA approved pembrolizumab for the first-line treatment of patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma.